Who Generates More Revenue? argenx SE or Alkermes plc

Revenue Race: Argenx SE vs. Alkermes plc

In the competitive landscape of biotechnology, revenue generation is a key indicator of success. Over the past decade, Alkermes plc has consistently outperformed Argenx SE in terms of revenue. From 2014 to 2023, Alkermes plc's revenue grew by approximately 169%, peaking at $1.66 billion in 2023. In contrast, Argenx SE, while showing impressive growth, started from a modest base, increasing its revenue by a staggering 26,600% to reach $1.23 billion in 2023.

A Decade of Growth

Alkermes plc maintained a steady upward trajectory, with revenues increasing year-on-year, except for a slight dip in 2020. Meanwhile, Argenx SE's revenue surged dramatically, particularly from 2021 onwards, reflecting its successful product launches and strategic market expansions. This data highlights the dynamic nature of the biotech industry, where innovation and strategic planning can lead to rapid growth.